Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma.
Source check: Source checked. Not independent scientific confirmation.
Finding: A 27-patient ccRCC cohort links pretreatment blood expression and learned models to RECIST response groups; exploratory, without independent replication. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.
Technology: H2O AutoML compared learned classifiers on pre-treatment blood-expression profiles to distinguish RECIST clinical-benefit and progressive-disease groups.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- H2O AutoML compared learned classifiers on pre-treatment blood-expression profiles to distinguish RECIST clinical-benefit and progressive-disease groups.
- Test and result
- The 27-patient study reports response-associated expression patterns and top classifier AUCs of 0.8–1.0.
- Limitation / still unknown
- A 60/40 split and cross-validation are described; small cohort, treatment regimens are mixed, and no independent cohort is reported.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3390/cancers15235637
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.